Sign In
Buy CRSP
$56.95
+4.87 (+9.35%)
At Close: Jun 04, 2026
3 Stocks That Every 20-Year-Old Should Buy Today
02:00pm, Sunday, 02'nd Jul 2023
Youth doesn't just have superficial advantages but rather can leverage significant financial rewards, particularly in the realm of stocks for young investors. Of course, a high-flying asset – such a
The 3 Most Undervalued Biotech Stocks to Buy Now: June 2023
02:00pm, Thursday, 29'th Jun 2023
Now is a great time to accumulate top undervalued biotech stocks. For one, the sector is recession-proof.
2 Under-the-Radar Biotech Stocks to Buy in 2023
07:45am, Wednesday, 28'th Jun 2023
Axsome Therapeutics' exciting pipeline promises a bright future for the company. CRISPR Therapeutics is on the verge of what could be the first of many approvals.
7 Growth Stocks That AI Predicts Will Deliver Triple-Digit Returns in 2023
07:00am, Wednesday, 28'th Jun 2023
This year's rally has seen many growth stocks deliver triple-digit returns, especially ones from the AI sector. Investors are willing to take more risks in 2023, and growth names have strongly trended
Wall Street Estimates That CRISPR Therapeutics Stock Could Jump 49%. Here's Why That's Right.
10:15am, Tuesday, 27'th Jun 2023
CRISPR Therapeutics now knows when regulators will rule on its exa-cel program. Getting approvals for both of the indications it's seeking would be huge.
3 Monster Stocks in the Making to Buy Right Now
06:07am, Sunday, 25'th Jun 2023
Axsome Therapeutics' pipeline features multiple potentially big winners. CRISPR Therapeutics could be at the beginning of a long-term success story.
Cathie Wood Is Buying This Growth Stock and Selling Its Competitor. Should You Follow Suit?
09:45am, Wednesday, 21'st Jun 2023
Cathie Wood has been loading up on Intellia Therapeutics. She's also trimming her holdings of CRISPR Therapeutics, a major competitor.
Buying This Growth Stock Hand-Over-Fist Right Now Could Make You a Lot Wealthier by 2030
07:15am, Wednesday, 21'st Jun 2023
CRISPR Therapeutics could soon launch its first two medicines. It could also penetrate much larger portions of the markets for its drugs over time.
Is CRISPR Therapeutics Stock a Buy Now?
05:30am, Wednesday, 21'st Jun 2023
CRISPR Therapeutics expects a regulatory decision on its first potential product later this year. The blood disorders candidate could generate blockbuster revenue.
3 Cathie Wood Investments That Could Deliver Superior Returns
09:15am, Saturday, 17'th Jun 2023
Intellia Therapeutics and CRISPR Therapeutics are clinical-stage gene-editing companies. Block is one of the primary fintech companies.
Where Will CRISPR Therapeutics Be in 10 Years?
09:45am, Wednesday, 14'th Jun 2023
CRISPR is trading for less than a third of what it did a little more than two years ago. Its lead therapy could be approved by the FDA later this year or early next year.
CRISPR Therapeutics to Participate in Goldman Sachs 44th Annual Global Healthcare Conference
09:00am, Tuesday, 13'th Jun 2023
ZUG, Switzerland and CAMBRIDGE, Mass., June 13, 2023 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for ser
This Move Is a First for the FDA. Could It Signal a Big Turning Point for CRISPR Therapeutics?
05:30am, Tuesday, 13'th Jun 2023
The FDA is reviewing CRISPR Therapeutics' candidate to treat two blood disorders -- illnesses with limited treatment options today. A nod would give the company its first commercialized product.
5 Stocks to Buy With Explosive 500% Potential
11:51am, Monday, 12'th Jun 2023
This article is an excerpt from the InvestorPlace Digest newsletter. To get news like this delivered straight to your inbox, click here.
2 Biotech Stocks That Could Help Make You a Fortune
07:30am, Monday, 12'th Jun 2023
CRISPR Therapeutics' fortunes may soon change for the better. Eli Lily with its strong pipeline has a favorable outlook ahead.
